Johnson & Johnson (JNJ) Set to Release Q2 2026 Earnings Amid Market Anticipation

J&J Stock Slips Despite Earnings Beat as Company Raises Guidance Toward $100 Billion Sales Milestone Today

Johnson & Johnson's stock fell despite exceeding Q2 earnings expectations, as investor optimism had already been priced in. The company rais

Why Johnson & Johnson (JNJ) Stock Declined Despite Strong Q2 Earnings Beat

Johnson & Johnson (JNJ) shares fell 2% despite beating Q2 estimates with $2.90 EPS and $25.31B revenue, while raising full-year guidance on

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ⁠Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday and also increased its full-year sales and ⁠p

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

By Michael Erman July 15 (Reuters) - Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as stron

What to Expect From DuPont’s Q2 2026 Earnings Report

What to Expect From Williams Companies' Q2 2026 Earnings Report